ARTICLE
|
doi:10.20944/preprints202310.1726.v1
Subject:
Medicine And Pharmacology,
Medicine And Pharmacology
Keywords:
dacomitinib; EGFR inhibitor; overall survival; pharmacokinetics; progression-free survival; proton pump inhibitors
Online: 27 October 2023 (07:06:07 CEST)